Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02315326 |
Title | Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Memorial Sloan Kettering Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Memorial Sloan Kettering Basking Ridge | RECRUITING | Basking Ridge | New Jersey | United States | Details | |
Memorial Sloan Kettering Monmouth | RECRUITING | Middletown | New Jersey | 07748 | United States | Details |
Memorial Sloan Kettering Bergen | RECRUITING | Montvale | New Jersey | 07645 | United States | Details |
Memorial Sloan Kettering Commack | RECRUITING | Commack | New York | 11725 | United States | Details |
Memorial Sloan Kettering Westchester | RECRUITING | Harrison | New York | 10604 | United States | Details |
Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 10065 | United States | Details |
Memorial Sloan Kettering Nassau | RECRUITING | Uniondale | New York | 11553 | United States | Details |